Global Medical Breakthrough: Kurdish Researcher Develops First Effective Treatment for Cervical Cancer
ARK News.. A research team led by Dr. Hazmat Abdul Khaleq, a professor at the College of Medicine at the University of Duhok, has developed the first effective treatment for cervical cancer—marking a historic milestone in global medical research.
The discovery is the result of five years of continuous research and 12 specialized studies, carried out in collaboration with the University of Duhok and Hungary's Semmelweis University (SOTE). The team successfully developed a new drug capable of eliminating 95% of small cancerous cells in the cervix.
Dr. Abdul Khaleq, who served as the lead researcher, stated that the team included nine international scientists. Among them was his wife, Dr. Shelan—also a professor of medicine—who co-led the research efforts during their time in Hungary.
The treatment is derived from a rare plant known as Centra Palace, which grows in select African countries. Initial clinical trials have shown highly promising results, and the medication is expected to be made available soon in the Kurdistan Region.
According to Dr. Abdul Khaleq, the breakthrough originated from research into traditional medicinal plants used in Nigeria. A similar plant was later discovered in Kurdistan, opening the door to further in-depth study.
The team is now preparing to enter the “mass production phase,” which involves manufacturing the drug at scale and conducting broader patient trials. This phase requires substantial institutional support and funding—estimated in the millions of dollars—and is projected to span several years.
In 2023, Dr. Abdul Khaleq developed a second version of the drug in Hungary using alternative components. He named the new formulation “Kurdistan,” and it has since been officially registered with international pharmaceutical authorities.
This achievement reinforces the global presence of Kurdish scientific talent and offers a transformative contribution to the ongoing fight against cancer—bringing renewed hope to millions of patients worldwide.
360
